New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 9, 2013
08:32 EDTARRYArray BioPharma announces positive data for filanesib
Across multiple studies, filanesib has demonstrated activity in heavily pre-treated MM patients, with a consistent safety profile including no drug-induced peripheral neuropathy and limited non‑hematologic toxicity. Adverse events are generally limited to transient, non-cumulative and predominantly asymptomatic hematologic effects.
News For ARRY From The Last 14 Days
Check below for free stories on ARRY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ARRY

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use